These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3012971)

  • 1. Interaction of DNA polymerase and nucleotide analog triphosphates.
    Frank KB; Chiou JF; Cheng YC
    Adv Enzyme Regul; 1985; 24():377-84. PubMed ID: 3012971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutually exclusive inhibition of herpesvirus DNA polymerase by aphidicolin, phosphonoformate, and acyclic nucleoside triphosphates.
    Frank KB; Cheng YC
    Antimicrob Agents Chemother; 1985 Apr; 27(4):445-8. PubMed ID: 2988429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinctive properties of DNA polymerases induced by herpes simplex virus type-1 and Epstein-Barr virus.
    Allaudeen HS
    Antiviral Res; 1985 Feb; 5(1):1-12. PubMed ID: 2984987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of RNA- and DNA-dependent duck hepatitis B virus DNA polymerase activity by nucleoside and pyrophosphate analogs.
    Löfgren B; Nordenfelt E; Oberg B
    Antiviral Res; 1989 Dec; 12(5-6):301-10. PubMed ID: 2483879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Herpes simplex virus type 1 and human DNA polymerase interactions with 2'-deoxyguanosine 5'-triphosphate analogues. Kinetics of incorporation into DNA and induction of inhibition.
    Reardon JE
    J Biol Chem; 1989 Nov; 264(32):19039-44. PubMed ID: 2553730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of herpes simplex virus-induced DNA polymerases and cellular DNA polymerase alpha by triphosphates of acyclic guanosine analogs.
    Larsson A; Sundqvist A; Parnerud AM
    Mol Pharmacol; 1986 Jun; 29(6):614-21. PubMed ID: 3012321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the DNA polymerases induced by a group of herpes simplex virus type I variants selected for growth in the presence of phosphonoformic acid.
    Derse D; Bastow KF; Cheng Y
    J Biol Chem; 1982 Sep; 257(17):10251-60. PubMed ID: 6286645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel interaction of aphidicolin with herpes simplex virus DNA polymerase and polymerase-associated exonuclease.
    Frank KB; Derse DD; Bastow KF; Cheng YC
    J Biol Chem; 1984 Nov; 259(21):13282-6. PubMed ID: 6092371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of herpes simplex virus DNA polymerase by purine ribonucleoside monophosphates.
    Frank KB; Cheng YC
    J Biol Chem; 1986 Feb; 261(4):1510-3. PubMed ID: 3003073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physical mapping of drug resistance mutations defines an active center of the herpes simplex virus DNA polymerase enzyme.
    Knopf KW; Kaufman ER; Crumpacker C
    J Virol; 1981 Sep; 39(3):746-57. PubMed ID: 6270349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiherpesvirus activity and mechanism of action of indolo-(2,3-b)quinoxaline and analogs.
    Harmenberg J; Wahren B; Bergman J; Akerfeldt S; Lundblad L
    Antimicrob Agents Chemother; 1988 Nov; 32(11):1720-4. PubMed ID: 2855298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of Epstein-Barr virus DNA polymerase with aphidicolin, phosphonoformate and 5'-GMP.
    Li JS; Cheng YC
    Virus Genes; 1988 Jul; 1(4):369-75. PubMed ID: 2852412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro mutagenesis of the herpes simplex virus type 1 DNA polymerase gene results in altered drug sensitivity of the enzyme.
    Matthews JT; Carroll RD; Stevens JT; Haffey ML
    J Virol; 1989 Nov; 63(11):4913-8. PubMed ID: 2552170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral effects of phosphonoformate (PFA, foscarnet sodium).
    Oberg B
    Pharmacol Ther; 1982; 19(3):387-415. PubMed ID: 6201932
    [No Abstract]   [Full Text] [Related]  

  • 15. Mechanism of action of foscarnet against viral polymerases.
    Crumpacker CS
    Am J Med; 1992 Feb; 92(2A):3S-7S. PubMed ID: 1371038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Inhibitory effect of various analogs of nucleoside-5'-triphosphates on DNA synthesis catalyzed by DNA polymerase from herpes simplex virus type I].
    Kilesso TIu; Shobukhov VM; Papchikhin AV; Galegov GA
    Mol Gen Mikrobiol Virusol; 1987 Oct; (10):41-4. PubMed ID: 2828934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of inhibition of Epstein-Barr virus replication by phosphonoformic acid.
    Datta AK; Hood RE
    Virology; 1981 Oct; 114(1):52-9. PubMed ID: 6269292
    [No Abstract]   [Full Text] [Related]  

  • 18. Susceptibility of phosphonoformic acid-resistant herpes simplex virus variants to arabinosylnucleosides and aphidicolin.
    Bastow KF; Derse DD; Cheng YC
    Antimicrob Agents Chemother; 1983 Jun; 23(6):914-7. PubMed ID: 6311091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aphidicolin resistance in herpes simplex virus type I reveals features of the DNA polymerase dNTP binding site.
    Hall JD; Wang YS; Pierpont J; Berlin MS; Rundlett SE; Woodward S
    Nucleic Acids Res; 1989 Nov; 17(22):9231-44. PubMed ID: 2555788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of hepatitis B virus DNA polymerase.
    Goto Y; Yamashita T; Arens M; Takahashi T; Hashimoto T
    Jpn J Med Sci Biol; 1984 Feb; 37(1):9-18. PubMed ID: 6204081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.